Infectious Diseases (except HIV/AIDS)
-
Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections
This article has 23 authors:Reviewed by ScreenIT
-
‘Anatomy of SARS-CoV-2 outbreak of ‘vaccinated’: An observational case-control study of COVID-19 breakthrough infections, COVID-19 appropriate behavior and anti-spike-IgG response as a correlate of protection in Medical college students at Rural Medical College, India
This article has 8 authors:Reviewed by ScreenIT
-
Comparative diagnostic performance of the new chromatographic Affimer ® -based rapid antigen detection against SARS-CoV-2 and other standard antigen tests for COVID-19 in a clinical setting
This article has 7 authors:Reviewed by ScreenIT
-
Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine
This article has 7 authors:Reviewed by ScreenIT
-
Adverse events following COVISHIELD (ChAdOx1nCoV-19) vaccination among health care workers in Sri Lanka; a multi-centre cross sectional survey
This article has 17 authors:Reviewed by ScreenIT
-
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
This article has 24 authors:Reviewed by ScreenIT
-
TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies
This article has 22 authors:Reviewed by ScreenIT
-
Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time
This article has 17 authors:Reviewed by ScreenIT
-
Implementing SARS-CoV-2 Rapid Antigen Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study
This article has 13 authors:Reviewed by ScreenIT
-
C-reactive protein-guided use of procalcitonin in COVID-19
This article has 14 authors:Reviewed by ScreenIT